Bilirubin Chemistry and Metabolism; Harmful and Protective Aspects
The DOI matches its Crossref record; 91 of the 91 references it cites were found in a registry or an index.
Abstract
Unconjugated bilirubin (UCB), the principal mammalian bile pigment, is the end product of heme catabolism. Both belong to the superfamily of tetrapyrrolic compounds that serve multiple biological functions in animals and plants. Its six internal hydrogen bonds give UCB a unique structure responsible for its physico-chemical properties and biological effects. Like many weakly-polar, poorly-soluble compounds, UCB is transported in blood tightly bound to albumin, with less than 0.01% of total bilirubin circulating in an unbound form (free bilirubin, Bf). This fraction governs the diffusion of UCB into tissues, and therefore Bf is responsible for both its beneficial and toxic effects on cells. Although, UCB was long thought to be a non-functional waste product, recent studies have shown that the antioxidant effects of mildly elevated serum bilirubin levels, as well as activation of heme oxygenase, may protect against diseases associated with oxidative stress, such as atherosclerosis. By contrast, markedly elevated serum UCB levels may cause severe neurological damage, especially in neonates. The regulation of cellular UCB content, by its conjugation, oxidation, and export, are, therefore of paramount importance to cellular health.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bilirubin Is an Antioxidant of Possible Physiological Importance
Stocker, R., Yamamoto, Y., McDonagh, A. F., Glazer, A. N., & Ames, B. N. (1987) · Science · doi:10.1126/science.3029864 · Cited by 2,948
THE HEME OXYGENASE SYSTEM:A Regulator of Second Messenger Gases
Maines, M. D. (1997) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.37.1.517 · Cited by 2,505
Heme Oxygenase-1/Carbon Monoxide: From Basic Science to Therapeutic Applications
Ryter, S. W., Alam, J., & Choi, A. M. K. (2006) · Physiological Reviews · doi:10.1152/physrev.00011.2005 · Cited by 2,307
Bosma, P. J., Chowdhury, J. R., Bakker, C., Gantla, S., de Boer, A., Oostra, B. A., Lindhout, D., Tytgat, G. N. J., Jansen, P. L. M., Elferink, R. P. J. O., et al. (1995) · New England Journal of Medicine · doi:10.1056/nejm199511023331802 · Cited by 1,447
Biliverdin reductase: A major physiologic cytoprotectant
Barañano, D. E., Rao, M., Ferris, C. D., & Snyder, S. H. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.252626999 · Cited by 1,088
LRP: a multifunctional scavenger and signaling receptor
Herz, J., & Strickland, D. K. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13992 · Cited by 908
Smooth muscle cell-derived carbon monoxide is a regulator of vascular cGMP.
Morita, T., Perrella, M. A., Lee, M. E., & Kourembanas, S. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.5.1475 · Cited by 707
Expression of heme oxygenase-1 can determine cardiac xenograft survival
Soares, M. P., Lin, Y., Anrather, J., Csizmadia, E., Takigami, K., Sato, K., Grey, S. T., Colvin, R. B., Choi, A. M., Poss, K. D., et al. (1998) · Nature Medicine · doi:10.1038/2063 · Cited by 612
Paulusma, C. C., Kool, M., Bosma, P. J., Scheffer, G. L., ter Borg, F., Scheper, R. J., Tytgat, G. N., Borst, P., Baas, F., & Elferink, R. O. (1997) · Hepatology · doi:10.1002/hep.510250635 · Cited by 552
Placental adaptive responses and fetal programming
Myatt, L. (2006) · The Journal of Physiology · doi:10.1113/jphysiol.2006.104968 · Cited by 534
Hepatic Uptake of Bilirubin and Its Conjugates by the Human Organic Anion Transporter SLC21A6
Cui, Y., König, J., Leier, I., Buchholz, U., & Keppler, D. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m004968200 · Cited by 515
Association of low serum concentration of bilirubin with increased risk of coronary artery disease
Schwertner, H. A., Jackson, W. G., & Tolan, G. (1994) · Clinical Chemistry · doi:10.1093/clinchem/40.1.18 · Cited by 474
Amersi, F., Buelow, R., Kato, H., Ke, B., Coito, A. J., Shen, X.-D., Zhao, D., Zaky, J., Melinek, J., Lassman, C. R., et al. (1999) · Journal of Clinical Investigation · doi:10.1172/jci7903 · Cited by 474
Brüne, B., & Ullrich, V (1987) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)13029-0 · Cited by 471
Furchgott, R. F., & Jothianandan, D. (1991) · Journal of Vascular Research · doi:10.1159/000158843 · Cited by 469
Evolution of Catalases from Bacteria to Humans
Zamocky, M., Furtmüller, P. G., & Obinger, C. (2008) · Antioxidants & Redox Signaling · doi:10.1089/ars.2008.2046 · Cited by 465
Gilbert syndrome and ischemic heart disease: a protective effect of elevated bilirubin levels
Vı́tek, L., Jirsa, M., Brodanová, M., Kaláb, M., Mareček, Z., Danzig, V., Novotný, L., & Kotal, P. (2002) · Atherosclerosis · doi:10.1016/s0021-9150(01)00601-3 · Cited by 429
Bilirubin in clinical practice: a review
Fevery, J. (2008) · Liver International · doi:10.1111/j.1478-3231.2008.01716.x · Cited by 374
The role of heme oxygenase-1 promoter polymorphisms in human disease
Exner, M., Minar, E., Wagner, O., & Schillinger, M. (2004) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2004.07.008 · Cited by 358
Bilirubin toxicity in the developing nervous system
Shapiro, S. M. (2003) · Pediatric Neurology · doi:10.1016/j.pediatrneurol.2003.09.011 · Cited by 350
Morita, T., & Kourembanas, S. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118334 · Cited by 350
Novotný, L., & Vítek, L. (2003) · Experimental Biology and Medicine · doi:10.1177/15353702-0322805-29 · Cited by 347
Kikuchi, S., Hata, M., Fukumoto, K., Yamane, Y., Matsui, T., Tamura, A., Yonemura, S., Yamagishi, H., Keppler, D., Tsukita, S., et al. (2002) · Nature Genetics · doi:10.1038/ng905 · Cited by 308
Purification and characterization of biliverdin reductase from rat liver.
Kutty, R. K., & Maines, M. D. (1981) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)69552-9 · Cited by 300
Induction of heme oxygenase-1 inhibits the monocyte transmigration induced by mildly oxidized LDL.
Ishikawa, K., Navab, M., Leitinger, N., Fogelman, A. M., & Lusis, A. J. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119634 · Cited by 289
Schaer, D. J., Schaer, C. A., Buehler, P. W., Boykins, R. A., Schoedon, G., Alayash, A. I., & Schaffner, A. (2006) · Blood · doi:10.1182/blood-2005-03-1014 · Cited by 285 · cited 1×
“During intravascular hemolysis the released hemoglobin binds to serum haptoglobin, forming complexes that are removed from the circulation by binding to a CD163 specific scavenger receptor present on Kupffer cells, as well as splenic and bone marrow macrophages [18].”
BackgroundExpression of heme oxygenase-1 in atherosclerotic lesions.
Wang, L.-J., Lee, T., Lee, F.-Y., Pai, R., & Chau, L. (1998) · Europe PMC (PubMed Central) · Cited by 254
Senafi, S. B., Clarke, D. J., & Burchell, B. (1994) · Biochemical Journal · doi:10.1042/bj3030233 · Cited by 238
Tukey, R. H., & Strassburg, C. P. (2001) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)12228-6 · Cited by 237
Berde, C. B., Hudson, B. S., Simoni, R. D., & Sklar, L. A. (1979) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)37930-9 · Cited by 229
The Heme Catabolic Pathway and its Protective Effects on Oxidative Stress‐Mediated Diseases
(2007) · Advances in Clinical Chemistry · doi:10.1016/s0065-2423(06)43001-8 · Cited by 209
Lampe, J. W., Bigler, J., Horner, N. K., & Potter, J. D. (1999) · Pharmacogenetics · doi:10.1097/00008571-199906000-00009 · Cited by 205
Clinical Potential of Spirulina as a Source of Phycocyanobilin
McCarty, M. F. (2007) · Journal of Medicinal Food · doi:10.1089/jmf.2007.621 · Cited by 199 · cited 1×
“This is true not only for biliverdin and bilirubin [3], but also for algal phycocyanobilins [4];”
BackgroundMolecular basis of bilirubin-induced neurotoxicity
Ostrow, J. D., Pascolo, L., Brites, D., & Tiribelli, C. (2004) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2003.12.003 · Cited by 189
Self-citationHeme Oxygenase-1 as a Therapeutic Target in Neurodegenerative Diseases and Brain Infections
Cuadrado, A., & Rojo, A. (2008) · Current Pharmaceutical Design · doi:10.2174/138161208783597407 · Cited by 173
Coito, A. J., Buelow, R., Shen, X., Amersi, F. F., Moore, C., Volk, H., Busuttil, R. W., & Kupiec‐Weglinski, J. W. (2002) · Transplantation · doi:10.1097/00007890-200207150-00017 · Cited by 164
Lerner-Marmarosh, N., Shen, J., Torno, M. D., Kravets, A., Hu, Z., & Maines, M. D. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0502173102 · Cited by 158
BRINK, M., SLORS, J., KEULEMANS, Y., MOK, K., DEWAART, D., CAREY, M., GROEN, A., & TYTGAT, G. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70507-x · Cited by 158
New concepts in bilirubin encephalopathy
Ostrow, J. D., Pascolo, L., Shapiro, S. M., & Tiribelli, C. (2003) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.2003.01261.x · Cited by 153
Self-citationRole of ligandin in transfer of bilirubin from plasma into liver.
Wolkoff, A. W., Goresky, C. A., Sellin, J., Gatmaitan, Z., & Arias, I. M. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.236.6.e638 · Cited by 148
New Insights into Biliverdin Reductase Functions: Linking Heme Metabolism to Cell Signaling
Maines, M. D. (2005) · Physiology · doi:10.1152/physiol.00029.2005 · Cited by 141
Gilbert's disease and atazanavir: From phenotype to UDP-glucuronosyltransferase haplotype
Lankisch, T. O., Möbius, U., Wehmeier, M., Behrens, G. M. N., Manns, M. P., Schmidt, R. E., & Strassburg, C. P. (2006) · Hepatology · doi:10.1002/hep.21361 · Cited by 139
Angiotensin II–Induced Hypertension Increases Heme Oxygenase-1 Expression in Rat Aorta
Ishizaka, N., León, H. D., Laursen, J. B., Fukui, T., Wilcox, J. N., Keulenaer, G. W. D., Griendling, K. K., & Alexander, R. W. (1997) · Circulation · doi:10.1161/01.cir.96.6.1923 · Cited by 139
THE ENZYMATIC DEGRADATION OF HEMOGLOBIN TO BILE PIGMENTS BY MACROPHAGES
Pimstone, N. R., Tenhunen, R., Seitz, P. T., Marver, H. S., & Schmid, R. (1971) · The Journal of Experimental Medicine · doi:10.1084/jem.133.6.1264 · Cited by 127
Enterohepatic cycling of bilirubin as a cause of ‘black’ pigment gallstones in adult life
Vı́tek, L., & Carey, M. C. (2003) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.2003.01214.x · Cited by 118
Physical-Chemical Pathogenesis of Pigment Gallstones
Cahalane, M. J., Neubrand, M., & Carey, M. C. (1988) · Seminars in Liver Disease · doi:10.1055/s-2008-1040553 · Cited by 115
Salim, M., Brown-Kipphut, B. A., & Maines, M. D. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m010753200 · Cited by 115
Kravets, A., Hu, Z., Miralem, T., Torno, M. D., & Maines, M. D. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m314251200 · Cited by 107
Kutty, R. K., & Maines, M. D. (1982) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)33968-1 · Cited by 106
Lerner‐Marmarosh, N., Miralem, T., Gibbs, P., & Maines, M. D. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0800750105 · Cited by 106
Biphasic Decrease of Radioactive Hemoprotein from Liver Microsomal CO-binding Particles
Levin, W., & Kuntzman, R. G. (1969) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)83421-4 · Cited by 105
Köhle, C., Möhrle, B. P., Münzel, P., Schwab, M. G., Wernet, D., Badary, O. A., & Bock, K. W. (2003) · Biochemical Pharmacology · doi:10.1016/s0006-2952(03)00074-1 · Cited by 102
Ionized Calcium in Body Fluids
Robertson, W., Marshall, R. W., & Bowers, G. N., Jr. (1981) · CRC Critical Reviews in Clinical Laboratory Sciences · doi:10.3109/10408368109105869 · Cited by 99
Falcão, A. S., Fernandes, A. M. A., Brito, M. A., Silva, R. F. M., & Brites, D. M. T. O. (2006) · Acta Neuropathologica · doi:10.1007/s00401-006-0078-4 · Cited by 97
Characterization of Cyanobacterial Biliverdin Reductase
Schluchter, W. M., & Glazer, A. N. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.21.13562 · Cited by 93
BILIRUBIN AND UROBILINS IN GERMFREE, EX-GERMFREE, AND CONVENTIONAL RATS
Gustafsson, B. E., & Lanke, L. S. (1960) · The Journal of Experimental Medicine · doi:10.1084/jem.112.6.975 · Cited by 90
Induction of long-term cardiac allograft survival by heme oxygenase-1 gene transfer
Braudeau, C., Bouchet, D., Tesson, L., Iyer, S., Remy, S., Buelow, R., Anegón, I., & Chauveau, C. (2004) · Gene Therapy · doi:10.1038/sj.gt.3302208 · Cited by 85
Tipping, E., KETTERER, B., & Christodoulides, L. G. (1979) · Biochemical Journal · doi:10.1042/bj1800327 · Cited by 85
Bhutani, V. K., Maisels, M. J., Stark, A. R., & Buonocore, G. (2008) · Neonatology · doi:10.1159/000113463 · Cited by 84
The Human Organic Anion Transport Protein SLC21A6 Is Not Sufficient for Bilirubin Transport
Wang, P., Kim, R. B., Chowdhury, J. R., & Wolkoff, A. W. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m301100200 · Cited by 84
Beri, R., & Chandra, R. (1993) · Drug Metabolism Reviews · doi:10.3109/03602539308993973 · Cited by 84
Marked endogenous activation of the CYP1A1 and CYP1A2 genes in the congenitally jaundiced Gunn rat.
Kapitulnik, J., & Gonzalez, F. J. (1993) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)13648-1 · Cited by 83
Nakayama, M., Takahashi, K., Komaru, T., Fukuchi, M., Shioiri, H., Sato, K.-I., Kitamuro, T., Shirato, K., Yamaguchi, T., Suematsu, M., et al. (2001) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/hq0801.093592 · Cited by 79
Cerebroprotective Functions of HO-2
Parfenova, H., & Leffler, C. W. (2008) · Current Pharmaceutical Design · doi:10.2174/138161208783597380 · Cited by 78
Fevery, J., Blanckaert, N. J. C., Leroy, P., Michiels, R., & Heirwegh, K. P. M. (1983) · Hepatology · doi:10.1002/hep.1840030207 · Cited by 77
The impact of intestinal microflora on serum bilirubin levels
Vı́tek, L., Zelenka, J., Zadinová, M., & Malina, J. (2004) · Journal of Hepatology · doi:10.1016/j.jhep.2004.10.012 · Cited by 76
Heme catabolism by heme oxygenase: physiology, regulation, and mechanism of action.
Schacter, B. A. (1988) · PubMed · Cited by 76
McDonagh, A. F., Palma, L. A., & Schmid, R. (1981) · Biochemical Journal · doi:10.1042/bj1940273 · Cited by 74
SHARMA, H. S., Maulik, N., Gho, B. C. G., DAS, D. K., & Verdouw, P. D. (1996) · Molecular and Cellular Biochemistry · doi:10.1007/bf00227888 · Cited by 69
Hypoxia-induced changes in the expression of rat hepatobiliary transporter genes
Fouassier, L., Beaussier, M., Schiffer, E. R. C., Rey, C., Barbu, V., Mergey, M., Wendum, D., Callard, P., Scoazec, J., Lasnier, E., et al. (2007) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00175.2006 · Cited by 69
The differential diagnosis of Crigler—Najjar disease, types 1 and 2, by bile pigment analysis
Sinaasappel, M., & Jansen, P. L. M. (1991) · Gastroenterology · doi:10.1016/0016-5085(91)80026-6 · Cited by 63
Vítek, L., Majer, F., Muchová, L., Zelenka, J., Jirásková, A., Branny, P., Malina, J., & Ubik, K. (2006) · Journal of Chromatography B · doi:10.1016/j.jchromb.2006.01.032 · Cited by 59
Bernhard, K., Ritzel, G., & Steiner, K. U. (1954) · Helvetica Chimica Acta · doi:10.1002/hlca.19540370139 · Cited by 59
Heme Oxygenase: A Target Gene for Anti-Diabetic and Obesity
Abraham, N. G., Tsenovoy, P. L., McClung, J. A., & Drummond, G. S. (2008) · Current Pharmaceutical Design · doi:10.2174/138161208783597371 · Cited by 57
Midtvedt, T., Carlstedt‐Duke, B., Høverstad, T., Lingaas, E., Norin, E. L., Saxerholt, H., & Steinbakk, M. (1986) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1986.tb01300.x · Cited by 55
MICROBIAL CONVERSION OF BILIRUBIN TO UROBILINS IN VITRO AND IN VIVO
Midtvedt, T., & Gustafsson, B. E. (1981) · Acta Pathologica Microbiologica Scandinavica Section B Microbiology · doi:10.1111/j.1699-0463.1981.tb00152_89b.x · Cited by 53
HO, K. ‐., Hsu, S.-C., CHEN, J. ‐., & HO, L. ‐. C. (1986) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1986.tb01010.x · Cited by 50
Antioxidant status and lipid peroxidation in human feto-placental unit
Qanungo, S., Sen, A., & Mukherjea, M. (1999) · Clinica Chimica Acta · doi:10.1016/s0009-8981(99)00051-0 · Cited by 50
Vulapalli, R., Imai, N., & Liang, C. (1999) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.1999.0995 · Cited by 47
Serrano, M. A., Bayón, J. E., Pascolo, L., Tiribelli, C., Ostrow, J. D., González‐Gallego, J., & Marı́n, J. J. G. (2002) · Placenta · doi:10.1053/plac.2002.0838 · Cited by 47
Self-citationDecreased levels of advanced glycation end-products in patients with Gilbert syndrome.
Kalousová, M., Novotný, L., Zima, T., Braun, M., & Vítek, L. (2005) · PubMed · Cited by 44
Hepatocellular Sinusoidal Membrane Organic Anion Transport and Transporters
Wolkoff, A. W. (1996) · Seminars in Liver Disease · doi:10.1055/s-2007-1007225 · Cited by 42
Urinary excretion of oxidative metabolites of bilirubin in subjects with Gilbert syndrome
Vı́tek, L., Kraslova, I., Lucie Muchova, A., Novotný, L., & Yamaguchi, T. (2006) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2006.04564.x · Cited by 34
Sunlight-Induced Mutation of Bilirubin in a Long-Distance Runner
McDonagh, A. F. (1986) · New England Journal of Medicine · doi:10.1056/nejm198601093140217 · Cited by 25
Revalidation and rationale for high pKa values of unconjugated bilirubin
Ostrow, J. D., & Mukerjee, P. (2007) · BMC Biochemistry · doi:10.1186/1471-2091-8-7 · Cited by 22
Self-citationDALY, J. S. F., Little, J. M., Troxler, R. F., et al. (1967) · Nature · doi:10.1038/2161030a0 · Cited by 21
Aziz, S., Kotal, P., Leroy, P., Servaes, R., Eggermont, E., & Fevery, J. (2001) · Acta Paediatrica · doi:10.1111/j.1651-2227.2001.tb00260.x · Cited by 18
Phototherapy-Induced Covalent Binding of Bilirubin to Serum Albumin
Jori, G., Rossi, E., & Rubaltelli, F. F. (1980) · Pediatric Research · doi:10.1203/00006450-198012000-00020 · Cited by 15
A new voyage of discovery: transport through the hepatocyte.
Gollan, J. L., & Zucker, S. D. (1996) · PubMed · Cited by 6
Laboratory Methods for the Study of Tetrapyrroles
Smith, A. G., & Witty, M. (2003) · Humana Press eBooks · doi:10.1385/1-59259-243-0:1 · Cited by 1
Cited by
Human serum albumin: From bench to bedside
Fanali, G., di Masi, A., Trezza, V., Marino, M., Fasano, M., & Ascenzi, P. (2012) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2011.12.002 · Cited by 1,931
The role of oxidative stress in the pathophysiology of hypertension
Rodrigo, R., González, J., & Paoletto, F. (2011) · Hypertension Research · doi:10.1038/hr.2010.264 · Cited by 436
Bilirubin-Induced Neurologic Damage — Mechanisms and Management Approaches
Watchko, J. F., & Tiribelli, C. (2013) · New England Journal of Medicine · doi:10.1056/nejmra1308124 · Cited by 393
The Role of Bilirubin in Diabetes, Metabolic Syndrome, and Cardiovascular Diseases
Vítek, L. (2012) · Frontiers in Pharmacology · doi:10.3389/fphar.2012.00055 · Cited by 311
Han, Y., & Kim, S. Y. (2023) · Experimental & Molecular Medicine · doi:10.1038/s12276-022-00906-w · Cited by 201
Metadata
- Authors
- Vitek, L., & Ostrow, J.
- Venue
- Current Pharmaceutical Design
- Publisher
- Bentham Science Publishers Ltd.
- Published
- 2009-09-01
- Volume
- 15
- Issue
- 25
- Pages
- 2869-2883
- ISSN
- 1381-6128 (ISSN-L)
- OpenAlex
- W2083762023
- Cited by
- 252
- References
- 91
- FWCI
- 8.77
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.